Supernus to Present at Two November Healthcare Conferences
November 12 2019 - 4:05PM
Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical
company focused on developing and commercializing products for the
treatment of central nervous system (CNS) diseases, today announced
that the Company's management will present a Company overview and
update, as well as host investor meetings, at the following
November conferences:
Stifel 2019
Healthcare Conference |
Date: |
November 19, 2019 |
Time: |
1:50 p.m. ET |
Place: |
Lotte New York Palace Hotel,
New York |
Jefferies 2019
London Healthcare Conference |
Date: |
November 21, 2019 |
Time: |
2:40 p.m. GMT / 9:40 a.m.
ET |
Place: |
Waldorf Hilton, London,
UK |
Investors interested in arranging a meeting with the Company's
management during these conferences should contact the respective
conference coordinators.
A live webcast of the presentations can be accessed by visiting
‘Events & Presentations’ in the Investor Relations section on
the Company's website at www.supernus.com. An archived replay of
these webcasts will be available for 60 days on the Company's
website after the respective conferences.
About Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. is a pharmaceutical company
focused on developing and commercializing products for the
treatment of central nervous system (CNS) diseases. The Company
currently markets Trokendi XR® (extended-release topiramate) for
the prophylaxis of migraine and the treatment of epilepsy, and
Oxtellar XR® (extended-release oxcarbazepine) for the treatment of
epilepsy. The Company is also developing several product candidates
to address large market opportunities in the CNS market, including
SPN-812 for the treatment of ADHD and SPN-604 for the treatment of
bipolar disorder.
CONTACTS:
Jack A. Khattar, President and CEOGregory S. Patrick, Senior
Vice President and CFOSupernus Pharmaceuticals, Inc.Tel: (301)
838-2591
or
INVESTOR CONTACT:Peter VozzoWestwicke, an ICR CompanyOffice:
(443) 213-0505Mobile: (443) 377-4767Email:
peter.vozzo@westwicke.com
Supernus Pharmaceuticals (NASDAQ:SUPN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Supernus Pharmaceuticals (NASDAQ:SUPN)
Historical Stock Chart
From Apr 2023 to Apr 2024